![]() Orexo Orexo, a specialty pharmaceutical company, engages in the development and commercialization of drugs. | |||
Founding Date | Founding Date 2003 | Founding Date 1996 | Founding Date 1995 |
Type | Type Subsidiary | Type Public | Type Public |
Tags | |||
Locations | Locations Louisville, US HQ Buffalo, US Houston, US New Hyde Park, US Scottsdale, US Waltham, US Woodridge, US | Locations ID HQ | Locations Uppsala, SE HQ Uppsala, SE Morristown, US |
Employees | Employees 5791% increase | Employees 14,616 | Employees 110 |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) Rp12.8t (FY, 2025) | Revenue (est.) kr26m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods Rp7.7t (FY, 2025) | Cost of goods kr14.5m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit Rp5.2t (FY, 2025) | Gross profit kr18m (FY, 2025) |
Net income | Net income N/A | Net income Rp1.2t (FY, 2025) | Net income (kr403.3m) (FY, 2025) |

Orexo, a specialty pharmaceutical company, engages in the development and commercialization of drugs.
View company